To evaluate the efficacy of XELOX+Bevacizumab for patient with Metastatic Colorectal Cancer as second-line chemotherapy
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2619390
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: XELOX+ bevacizumab
Primary outcome(s): Response rate
Study Design: Single arm Non-randomized
创建时间：
2011-02-15
